Skip to content

Proteus OX2

by Lorne Laboratories Ltd United Kingdom EUDAMED

Ref 522005AModel Rapid Agglutination Febrile Antigen Kits

EMDN W0105011712

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-05060168051134 Basic UDI-DIDate7 Sep 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/IVDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
Rapid Agglutination Febrile Antigen Kits, 522005A
Primary DI / UDI-DI
05060168051134
Basic UDI-DI
B-05060168051134
EMDN Code
W0105011712 Proteus
Device Class
Class IVD General
Market of Registration
Malta

Manufacturer details

EUDAMED SRN
GB-MF-000029354
Authorised representative
Advena Limited MT-AR-000000234

Other devices from Lorne Laboratories Ltd

See all devices from Lorne Laboratories Ltd →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
  • Microbial Substances
  • Reagent
  • Professional Testing
Other properties (6)
  • Sterile: No
  • Human Tissues: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED 0c61e9f5-d0e8-45ca-8389-df3ad785a5bd 61 fields · synced 24 Oct 2026